Liposomal Encapsulated FSC231, a PICK1 Inhibitor, Prevents the Ischemia/Reperfusion-Induced Degradation of GluA2-Containing AMPA Receptors
Strokes remain one of the leading causes of disability within the United States. Despite an enormous amount of research effort within the scientific community, very few therapeutics are available for stroke patients. Cytotoxic accumulation of intracellular calcium is a well-studied phenomenon that o...
Main Authors: | Lindsay M. Achzet, Fanny Astruc-Diaz, Phillip H. Beske, Nicholas R. Natale, Travis T. Denton, Darrell A. Jackson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/5/636 |
Similar Items
-
Synaptic plasticity through activation of GluA3-containing AMPA-receptors
by: Maria C Renner, et al.
Published: (2017-08-01) -
Thiazole Derivatives as Modulators of GluA2 AMPA Receptors: Potent Allosteric Effects and Neuroprotective Potential
by: Mohammed Hawash
Published: (2023-11-01) -
Expression and Interaction Proteomics of GluA1- and GluA3-Subunit-Containing AMPARs Reveal Distinct Protein Composition
by: Sophie J. F. van der Spek, et al.
Published: (2022-11-01) -
GluA4 facilitates cerebellar expansion coding and enables associative memory formation
by: Katarzyna Kita, et al.
Published: (2021-07-01) -
Challenges for FSC Forest Certification: Audits in the Context of Pandemic COVID-19
by: Adelin-Ionuț Nicorescu, et al.
Published: (2021-07-01)